Cargando…
Variant Interpretation in Current Pharmacogenetic Testing
In the current marketplace, there are now more than a dozen commercial companies providing pharmacogenetic tests. Each company varies in the panel of genes they test and the variants they are able to screen for. The reports generated by these companies provide phenotypic interpretations of pharmacog...
Autores principales: | Luvsantseren, Sally, Whirl-Carrillo, Michelle, Sangkuhl, Katrin, Shin, Nancy, Wen, Alice, Empey, Philip, Alam, Benish, David, Sean, Dunnenberger, Henry M., Orlando, Lori, Altman, Russ, Palaniappan, Latha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712137/ https://www.ncbi.nlm.nih.gov/pubmed/33142667 http://dx.doi.org/10.3390/jpm10040204 |
Ejemplares similares
-
Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population
por: Verma, Shefali S., et al.
Publicado: (2022) -
Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)
por: Caudle, Kelly E., et al.
Publicado: (2017) -
Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group
por: Caudle, Kelly E., et al.
Publicado: (2019) -
Transfer learning enables prediction of CYP2D6 haplotype function
por: McInnes, Gregory, et al.
Publicado: (2020) -
Prediction of CYP2D6 phenotype from genotype across world populations
por: Gaedigk, Andrea, et al.
Publicado: (2017)